Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-25-080407

Options or other derivatives

  • Chief Financial Officer acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Roberts Brandi Chief Financial Officer 2025-06-02 Grant or award · Stock Option (Right to Buy) +500,000 500,000 D
Loading xslF345X05/ownership.xml…